BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017. [PMID: 18768944 DOI: 10.1056/nejmoa071098] [Cited by in Crossref: 1015] [Cited by in F6Publishing: 164] [Article Influence: 78.1] [Reference Citation Analysis]
Number Citing Articles
1 Campbell T, Bennett RG, Kotake Y, Kumar S. Updates in Ventricular Tachycardia Ablation. Korean Circ J 2021;51:15-42. [PMID: 33377327 DOI: 10.4070/kcj.2020.0436] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Santini M, Lunati M, Defaye P. Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD therapy (ADVANCED-D) Trial results. J Interv Card Electrophysiol. 2010;27:127-135. [PMID: 20087760 DOI: 10.1007/s10840-009-9454-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
3 Pang Y, Jin Q, Zhang N, Ren S, Ling T, Chen Y, Gu G, Shen Y, Wu L. High-energy defibrillation increases the dispersion of regional ventricular repolarization. J Interv Card Electrophysiol 2011;32:81-6. [PMID: 21671072 DOI: 10.1007/s10840-011-9589-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
4 Dichtl W, Wolber T, Paoli U, Brüllmann S, Stühlinger M, Berger T, Spuller K, Strasak A, Pachinger O, Haegeli LM, Duru F, Hintringer F. Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients. Clin Cardiol 2011;34:433-6. [PMID: 21678454 DOI: 10.1002/clc.20910] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
5 van der Heijden AC, van Rees JB, Levy WC, van der Bom JG, Cannegieter SC, de Bie MK, van Erven L, Schalij MJ, Borleffs CJ. Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment. Europace 2017;19:72-80. [PMID: 28130376 DOI: 10.1093/europace/euw005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Tereshchenko LG, Faddis MN, Fetics BJ, Zelik KE, Efimov IR, Berger RD. Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression. J Am Coll Cardiol 2009;54:822-8. [PMID: 19695461 DOI: 10.1016/j.jacc.2009.06.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
7 Aktas MK, Bennett AL, Younis A, Kutyifa V, Polonsky B, McNitt S, Zareba W, Rosero S, Goldenberg I. Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Heart Rhythm O2 2020;1:77-82. [PMID: 34113861 DOI: 10.1016/j.hroo.2020.04.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bunch TJ, Darby A, May HT, Ragosta M, Lim DS, Taylor AM, DiMarco JP, Ailawadi G, Revenaugh JR, Weiss JP, Mahapatra S. Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques. Europace 2012;14:709-14. [PMID: 22080473 DOI: 10.1093/europace/eur347] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
9 Cevik C, Nugent K, Perez-Verdia A, Fish RD. Prophylactic implantation of cardioverter defibrillators in idiopathic nonischemic cardiomyopathy for the primary prevention of death: a narrative review. Clin Cardiol 2010;33:254-60. [PMID: 20513063 DOI: 10.1002/clc.20757] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
10 Nakamura H, Niwano S, Fukaya H, Murakami M, Kishihara J, Satoh A, Yoshizawa T, Oikawa J, Ishizue N, Igarashi T, Fujiishi T, Ako J. Cardiac troponin T as a predictor of cardiac death in patients with left ventricular dysfunction. J Arrhythm 2017;33:463-8. [PMID: 29021851 DOI: 10.1016/j.joa.2017.07.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Cheng A, Zhang Y, Blasco-Colmenares E, Dalal D, Butcher B, Norgard S, Eldadah Z, Ellenbogen KA, Dickfeld T, Spragg DD, Marine JE, Guallar E, Tomaselli GF. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD). Circ Arrhythm Electrophysiol 2014;7:1084-91. [PMID: 25273351 DOI: 10.1161/CIRCEP.113.001705] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
12 Streitner F, Herrmann T, Kuschyk J, Lang S, Doesch C, Papavassiliu T, Streitner I, Veltmann C, Haghi D, Borggrefe M. Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention. PLoS One 2013;8:e63911. [PMID: 23675514 DOI: 10.1371/journal.pone.0063911] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
13 Conti S, Pala S, Biagioli V, Del Giorno G, Zucchetti M, Russo E, Marino V, Dello Russo A, Casella M, Pizzamiglio F, Catto V, Tondo C, Carbucicchio C. Electrical storm: A clinical and electrophysiological overview. World J Cardiol 2015;7:555-61. [PMID: 26413232 DOI: 10.4330/wjc.v7.i9.555] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
14 Cheng A, Dalal D, Butcher B, Norgard S, Zhang Y, Dickfeld T, Eldadah ZA, Ellenbogen KA, Guallar E, Tomaselli GF. Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description. J Am Heart Assoc 2013;2:e000083. [PMID: 23525420 DOI: 10.1161/JAHA.112.000083] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
15 Kreuz J, Horlbeck F, Schrickel J, Linhart M, Fimmers R, Mellert F, Nickenig G, Schwab JO. Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention. Clin Cardiol 2012;35:575-9. [PMID: 22707222 DOI: 10.1002/clc.22018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
16 Ille F, Sommer L. Wnt signaling: multiple functions in neural development. Cell Mol Life Sci. 2005;62:1100-1108. [PMID: 15928805 DOI: 10.1007/s00018-005-4552-2] [Cited by in Crossref: 117] [Cited by in F6Publishing: 116] [Article Influence: 7.3] [Reference Citation Analysis]
17 Goldfinger JZ, Adler ED. End-of-life options for patients with advanced heart failure. Curr Heart Fail Rep 2010;7:140-7. [PMID: 20585999 DOI: 10.1007/s11897-010-0017-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
18 Greenlee RT, Go AS, Peterson PN, Cassidy-Bushrow AE, Gaber C, Garcia-Montilla R, Glenn KA, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Kadish A, Magid DJ, McManus DD, Multerer D, Powers JD, Reifler LM, Reynolds K, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Masoudi FA. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network. J Am Heart Assoc 2018;7:e008292. [PMID: 29581222 DOI: 10.1161/JAHA.117.008292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Tokuda M, Kojodjojo P, Tung S, Tedrow UB, Nof E, Inada K, Koplan BA, Michaud GF, John RM, Epstein LM, Stevenson WG. Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance. J Am Heart Assoc 2013;2:e000072. [PMID: 23727700 DOI: 10.1161/JAHA.113.000072] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
20 Toise SC, Sears SF, Schoenfeld MH, Blitzer ML, Marieb MA, Drury JH, Slade MD, Donohue TJ. Psychosocial and cardiac outcomes of yoga for ICD patients: a randomized clinical control trial. Pacing Clin Electrophysiol 2014;37:48-62. [PMID: 23981048 DOI: 10.1111/pace.12252] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
21 Nishii N, Noda T, Nitta T, Aizawa Y, Ohe T, Kurita T. Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy. Int J Cardiol Heart Vasc 2021;34:100779. [PMID: 33997254 DOI: 10.1016/j.ijcha.2021.100779] [Reference Citation Analysis]
22 Chen J, Johnson G, Hellkamp AS, Anderson J, Mark DB, Lee KL, Bardy GH, Poole JE. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2013;61:2161-8. [PMID: 23541974 DOI: 10.1016/j.jacc.2013.02.046] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
23 Mallidi J, Nadkarni GN, Berger RD, Calkins H, Nazarian S. Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm 2011;8:503-10. [PMID: 21147263 DOI: 10.1016/j.hrthm.2010.12.015] [Cited by in Crossref: 80] [Cited by in F6Publishing: 54] [Article Influence: 7.3] [Reference Citation Analysis]
24 Aktaş MK, Younis A, Zareba W, Kutyifa V, Klein H, Daubert JP, Estes M, McNitt S, Polonsky B, Goldenberg I. Survival After Implantable Cardioverter-Defibrillator Shocks. J Am Coll Cardiol 2021;77:2453-62. [PMID: 34016257 DOI: 10.1016/j.jacc.2021.03.329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 AbdelWahab A, Sapp J. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. Curr Cardiol Rep 2017;19:105. [PMID: 28900864 DOI: 10.1007/s11886-017-0924-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 O'Day K, Levy WC, Johnson M, Jacobson AF. Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA. Appl Health Econ Health Policy 2016;14:361-73. [PMID: 26975999 DOI: 10.1007/s40258-016-0234-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
27 Bracke FA, van Gelder BM. Managing patients with advisory defibrillator leads: what can we learn from published data? Neth Heart J 2015;23:199-204. [PMID: 25884090 DOI: 10.1007/s12471-015-0669-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Yanagisawa S, Inden Y, Shimano M, Yoshida N, Ishikawa S, Kato H, Okumura S, Miyoshi-Fujii A, Nagao T, Yamamoto T, Mizutani Y, Ito T, Hirai M, Murohara T. Impact of cardiac resynchronization therapy-defibrillator implantation on the association between body mass index and prognosis in patients with heart failure. J Interv Card Electrophysiol 2015;43:269-77. [PMID: 26003807 DOI: 10.1007/s10840-015-0015-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
29 Clementy N, Bodin A, Bisson A, Teixeira-Gomes AP, Roger S, Angoulvant D, Labas V, Babuty D. The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy. Int J Mol Sci 2021;22:5003. [PMID: 34066832 DOI: 10.3390/ijms22095003] [Reference Citation Analysis]
30 Schuger C, Daubert JP, Brown MW, Cannom D, Estes NA 3rd, Hall WJ, Kayser T, Klein H, Olshansky B, Power KA, Wilber D, Zareba W, Moss AJ. Multicenter automatic defibrillator implantation trial: reduce inappropriate therapy (MADIT-RIT): background, rationale, and clinical protocol. Ann Noninvasive Electrocardiol 2012;17:176-85. [PMID: 22816536 DOI: 10.1111/j.1542-474X.2012.00531.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 3] [Article Influence: 3.6] [Reference Citation Analysis]
31 Bradfield J, Tung R, Boyle NG, Shivkumar K. Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes. Heart Fail Rev 2011;16:449-56. [PMID: 21451976 DOI: 10.1007/s10741-011-9241-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
32 Ukena C, Mahfoud F, Ewen S, Bollmann A, Hindricks G, Hoffmann BA, Linz D, Musat D, Pavlicek V, Scholz E, Thomas D, Willems S, Böhm M, Steinberg JS. Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry. Clin Res Cardiol 2016;105:873-9. [PMID: 27364940 DOI: 10.1007/s00392-016-1012-y] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
33 Alvarez CK, Cronin E, Baker WL, Kluger J. Heart failure as a substrate and trigger for ventricular tachycardia. J Interv Card Electrophysiol. 2019;56:229-247. [PMID: 31598875 DOI: 10.1007/s10840-019-00623-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
34 Tereshchenko LG, Cheng A, Fetics BJ, Butcher B, Marine JE, Spragg DD, Sinha S, Dalal D, Calkins H, Tomaselli GF, Berger RD. A new electrocardiogram marker to identify patients at low risk for ventricular tachyarrhythmias: sum magnitude of the absolute QRST integral. J Electrocardiol 2011;44:208-16. [PMID: 21093871 DOI: 10.1016/j.jelectrocard.2010.08.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
35 Wang S, Wu S, Xu L, Xiao F, Whinnett ZI, Vijayaraman P, Su L, Huang W. Feasibility and Efficacy of His Bundle Pacing or Left Bundle Pacing Combined With Atrioventricular Node Ablation in Patients With Persistent Atrial Fibrillation and Implantable Cardioverter-Defibrillator Therapy. J Am Heart Assoc 2019;8:e014253. [PMID: 31830874 DOI: 10.1161/JAHA.119.014253] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 13.5] [Reference Citation Analysis]
36 Assis FR, Yu DH, Zhou X, Sidhu S, Bapna A, Engelman ZJ, Misra S, Okada DR, Chrispin J, Berger R, Mandal K, Lee H, Tandri H. Minimally invasive transtracheal cardiac plexus block for sympathetic neuromodulation. Heart Rhythm 2019;16:117-24. [PMID: 30075280 DOI: 10.1016/j.hrthm.2018.07.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
37 Ajijola OA, Tung R, Shivkumar K. Ventricular tachycardia in ischemic heart disease substrates. Indian Heart J 2014;66 Suppl 1:S24-34. [PMID: 24568826 DOI: 10.1016/j.ihj.2013.12.039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
38 Janardhan AH, Li W, Fedorov VV, Yeung M, Wallendorf MJ, Schuessler RB, Efimov IR. A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails. J Am Coll Cardiol 2012;60:2393-8. [PMID: 23141483 DOI: 10.1016/j.jacc.2012.08.1001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
39 van Barreveld M, Dijkgraaf MGW, Hulleman M, Boersma LVA, Delnoy PPHM, Meine M, Tuinenburg AE, Theuns DAMJ, van der Voort PH, Kimman GP, Buskens E, Tijssen JPG, Bruinsma N, Verstraelen TE, Zwinderman AH, van Dessel PHFM, Wilde AAM; DO-IT investigators. Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator. Neth Heart J 2017;25:574-80. [PMID: 28785868 DOI: 10.1007/s12471-017-1016-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
40 Makimoto H, Zielke S, Clasen L, Lin T, Gerguri S, Müller P, Schmidt J, Bejinariu A, Kurt M, Brinkmeyer C, Stern M, Kelm M, Fürnkranz A. Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients. Eur J Med Res 2020;25:5. [PMID: 32183891 DOI: 10.1186/s40001-020-0401-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Grabowski M, Gawałko M, Michalak M, Cacko A, Kowara M, Kołodzińska A, Januszkiewicz Ł, Balsam P, Vitali Serdoz L, Winter J, Opolski G. Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center. Cardiol J 2019;26:360-7. [PMID: 29611175 DOI: 10.5603/CJ.a2018.0024] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Almehmadi F, Porta-Sánchez A, Ha ACT, Fischer HD, Wang X, Austin PC, Lee DS, Nanthakumar K. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry. J Am Heart Assoc 2017;6:e006220. [PMID: 28862957 DOI: 10.1161/JAHA.117.006220] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
43 Theuns DAMJ, Niazi K, Schaer BA, Sticherling C, Yap SC, Caliskan K. Reassessment of clinical variables in cardiac resynchronization defibrillator patients at the time of first replacement: Death after replacement of CRT (DARC) score. J Cardiovasc Electrophysiol 2021;32:1687-94. [PMID: 33825257 DOI: 10.1111/jce.15031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Strauss DG, Poole JE, Wagner GS, Selvester RH, Miller JM, Anderson J, Johnson G, McNulty SE, Mark DB, Lee KL, Bardy GH, Wu KC. An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial. Heart Rhythm 2011;8:38-45. [PMID: 20884379 DOI: 10.1016/j.hrthm.2010.09.071] [Cited by in Crossref: 47] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
45 Masoudi FA, Go AS, Magid DJ, Cassidy-Bushrow AE, Doris JM, Fiocchi F, Garcia-Montilla R, Glenn KA, Goldberg RJ, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Jackson N, Kadish A, Lauer M, Miller AW, Multerer D, Peterson PN, Reifler LM, Reynolds K, Saczynski JS, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Greenlee RT. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes 2012;5:e78-85. [PMID: 23170006 DOI: 10.1161/CIRCOUTCOMES.112.965368] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
46 Sasse P, Funken M, Beiert T, Bruegmann T. Optogenetic Termination of Cardiac Arrhythmia: Mechanistic Enlightenment and Therapeutic Application? Front Physiol 2019;10:675. [PMID: 31244670 DOI: 10.3389/fphys.2019.00675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
47 Kwon DH, Hachamovitch R, Adeniyi A, Nutter B, Popovic ZB, Wilkoff BL, Desai MY, Flamm SD, Marwick T. Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender. Heart 2014;100:206-13. [PMID: 24186562 DOI: 10.1136/heartjnl-2013-304261] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
48 Ladwig KH, Ronel J, Baumert J, Kolb C. [Psychological comorbidity and quality of life in patients with an implantable cardioverter/defribrillator (ICD)]. Herzschrittmacherther Elektrophysiol 2010;21:129-36. [PMID: 20552319 DOI: 10.1007/s00399-010-0082-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Krokhaleva Y, Vaseghi M. Update on prevention and treatment of sudden cardiac arrest. Trends Cardiovasc Med 2019;29:394-400. [PMID: 30449537 DOI: 10.1016/j.tcm.2018.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
50 Sturdivant JL, Gold MR. Is defibrillation testing of ICDs necessary? Nat Rev Cardiol 2012;9:618-9. [PMID: 23026864 DOI: 10.1038/nrcardio.2012.144] [Reference Citation Analysis]
51 Smith T, Theuns DA, Caliskan K, Jordaens L. Long-term follow-up of prophylactic implantable cardioverter-defibrillator-only therapy: comparison of ischemic and nonischemic heart disease. Clin Cardiol 2011;34:761-7. [PMID: 22038531 DOI: 10.1002/clc.20970] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
52 Zhou Y, Zhao S, Chen K, Hua W, Su Y, Chen S, Liang Z, Xu W, Zhang S. Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients. BMC Cardiovasc Disord 2019;19:230. [PMID: 31638918 DOI: 10.1186/s12872-019-1218-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Bui AL, Fonarow GC. Home monitoring for heart failure management. J Am Coll Cardiol. 2012;59:97-104. [PMID: 22222071 DOI: 10.1016/j.jacc.2011.09.044] [Cited by in Crossref: 113] [Cited by in F6Publishing: 58] [Article Influence: 12.6] [Reference Citation Analysis]
54 Al-Khatib SM, Hellkamp AS, Hernandez AF, Fonarow GC, Thomas KL, Al-Khalidi HR, Heidenreich PA, Hammill S, Yancy C, Peterson ED; Get With the Guidelines Steering Committee and Hospitals. Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time? Circulation 2012;125:1094-101. [PMID: 22287589 DOI: 10.1161/CIRCULATIONAHA.111.066605] [Cited by in Crossref: 85] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
55 Halliday BP, Cleland JG, Goldberger JJ, Prasad SK. Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future. Circulation 2017;136:215-31. [DOI: 10.1161/circulationaha.116.027134] [Cited by in Crossref: 105] [Cited by in F6Publishing: 36] [Article Influence: 26.3] [Reference Citation Analysis]
56 Piccini JP, Hellkamp AS, Whellan DJ, Ellis SJ, Keteyian SJ, Kraus WE, Hernandez AF, Daubert JP, Piña lL, O'Connor CM; HF-ACTION Investigators. Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing). JACC Heart Fail 2013;1:142-8. [PMID: 23936756 DOI: 10.1016/j.jchf.2013.01.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
57 Mustafa U, Dherange P, Reddy R, DeVillier J, Chong J, Ihsan A, Jones R, Duddyala N, Reddy P, Dominic P. Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018;7:e010156. [PMID: 30554547 DOI: 10.1161/JAHA.118.010156] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
58 Piccini JP, Al-Khatib SM, Hellkamp AS, Anstrom KJ, Poole JE, Mark DB, Lee KL, Bardy GH. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm 2011;8:393-400. [PMID: 21109025 DOI: 10.1016/j.hrthm.2010.11.033] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
59 Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, Levy WC, Poole JE. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial. JAMA Cardiol 2017;2:767-74. [PMID: 28724134 DOI: 10.1001/jamacardio.2017.1413] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
60 Sun H, Zhou J, Huang Z, Qu L, Lin N, Liang C, Dai R, Tang L, Tian F. Carbon nanotube-incorporated collagen hydrogels improve cell alignment and the performance of cardiac constructs. Int J Nanomedicine 2017;12:3109-20. [PMID: 28450785 DOI: 10.2147/IJN.S128030] [Cited by in Crossref: 49] [Cited by in F6Publishing: 17] [Article Influence: 12.3] [Reference Citation Analysis]
61 Tereshchenko LG, Han L, Cheng A, Marine JE, Spragg DD, Sinha S, Dalal D, Calkins H, Tomaselli GF, Berger RD. Beat-to-beat three-dimensional ECG variability predicts ventricular arrhythmia in ICD recipients. Heart Rhythm 2010;7:1606-13. [PMID: 20816873 DOI: 10.1016/j.hrthm.2010.08.022] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
62 Patton KK, Hellkamp AS, Lee KL, Mark DB, Johnson GW, Anderson J, Bardy GH, Poole JE; SCD-HeFT Investigators. Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2014;63:2702-8. [PMID: 24747100 DOI: 10.1016/j.jacc.2013.11.072] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
63 Briongos-Figuero S, Sánchez A, Pérez ML, Martínez-Ferrer JB, García E, Viñolas X, Arenal Á, Alzueta J, Basterra N, Rodríguez A, Lozano I, Muñoz-Aguilera R. Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices. J Interv Card Electrophysiol 2019;54:267-75. [PMID: 30523511 DOI: 10.1007/s10840-018-0494-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
64 Al Badarin FJ, Wimmer AP, Kennedy KF, Jacobson AF, Bateman TM. The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy. J Nucl Cardiol 2014;21:756-62; quiz 753-55, 763-5. [PMID: 25015681 DOI: 10.1007/s12350-014-9919-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
65 Guo Y, Zhang C, Ye T, Chen X, Liu X, Chen X, Sun Y, Qu C, Liang J, Shi S, Yang B. Pinocembrin ameliorates arrhythmias in rats with chronic ischaemic heart failure. Ann Med 2021;53:830-40. [PMID: 34060948 DOI: 10.1080/07853890.2021.1927168] [Reference Citation Analysis]
66 Chatterjee NA, Borgquist R, Chang Y, Lewey J, Jackson VA, Singh JP, Metlay JP, Lindvall C. Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator. Eur Heart J 2017;38:1485-94. [PMID: 28065904 DOI: 10.1093/eurheartj/ehw598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
67 Kutyifa V, Zareba W, Moss AJ. ICD programming to reduce shocks and improve outcomes. Curr Cardiol Rep 2014;16:496. [PMID: 24818705 DOI: 10.1007/s11886-014-0496-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
68 Proietti R, Joza J, Essebag V. Therapy for ventricular arrhythmias in structural heart disease: a multifaceted challenge. J Physiol 2016;594:2431-43. [PMID: 26621333 DOI: 10.1113/JP270534] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
69 Ezekowitz JA, Kaul P. The epidemiology and management of elderly patients with myocardial infarction or heart failure. Heart Fail Rev 2010;15:407-13. [PMID: 20213185 DOI: 10.1007/s10741-010-9162-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
70 Kolb C, Sturmer M, Babuty D, Sick P, Davy JM, Molon G, Schwab JO, Mantovani G, Wickliffe A, Lennerz C, Semmler V, Siot PH, Reif S. Relation between detection rate and inappropriate shocks in single versus dual chamber cardioverter-defibrillator--an analysis from the OPTION trial. Sci Rep 2016;6:21748. [PMID: 26892534 DOI: 10.1038/srep21748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
71 Niehues P, Frommeyer G, Reinke F, Eckardt L. [Subcutaneous implantable cardioverter-defibrillator : Current status and perspectives]. Herzschrittmacherther Elektrophysiol 2018;29:349-54. [PMID: 30306303 DOI: 10.1007/s00399-018-0593-8] [Reference Citation Analysis]
72 Hansen C, Loges C, Seidl K, Eberhardt F, Tröster H, Petrov K, Grönefeld G, Bramlage P, Birkenhauer F, Weiss C. INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact). BMC Cardiovasc Disord 2018;18:131. [PMID: 29954340 DOI: 10.1186/s12872-018-0864-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
73 Li A, Kaura A, Sunderland N, Dhillon PS, Scott PA. The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients. Arrhythm Electrophysiol Rev 2016;5:110-6. [PMID: 27617089 DOI: 10.15420/AER.2016.12.2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
74 Tilz RR, Eitel C, Lyan E, Yalin K, Liosis S, Vogler J, Brueggemann B, Eitel I, Heeger C, AlTurki A, Proietti R. Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials. Arrhythm Electrophysiol Rev 2019;8:173-9. [PMID: 31463054 DOI: 10.15420/aer.2019.31.3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
75 Vaseghi M, Barwad P, Malavassi Corrales FJ, Tandri H, Mathuria N, Shah R, Sorg JM, Gima J, Mandal K, Sàenz Morales LC, Lokhandwala Y, Shivkumar K. Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias. J Am Coll Cardiol 2017;69:3070-80. [PMID: 28641796 DOI: 10.1016/j.jacc.2017.04.035] [Cited by in Crossref: 151] [Cited by in F6Publishing: 104] [Article Influence: 37.8] [Reference Citation Analysis]
76 DeMazumder D, Lake DE, Cheng A, Moss TJ, Guallar E, Weiss RG, Jones SR, Tomaselli GF, Moorman JR. Dynamic analysis of cardiac rhythms for discriminating atrial fibrillation from lethal ventricular arrhythmias. Circ Arrhythm Electrophysiol 2013;6:555-61. [PMID: 23685539 DOI: 10.1161/CIRCEP.113.000034] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
77 Lopez EM, Malhotra R. Ventricular Tachycardia in Structural Heart Disease. J Innov Card Rhythm Manag 2019;10:3762-73. [PMID: 32477742 DOI: 10.19102/icrm.2019.100801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
78 Kobayashi Y. How to manage various arrhythmias and sudden cardiac death in the cardiovascular intensive care. J Intensive Care 2018;6:23. [PMID: 29686877 DOI: 10.1186/s40560-018-0292-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
79 Borne RT, Katz D, Betz J, Peterson PN, Masoudi FA. Implantable Cardioverter-Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review. J Am Heart Assoc 2017;6:e005515. [PMID: 28258050 DOI: 10.1161/JAHA.117.005515] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
80 Wallace BC, Allen LA, Knoepke CE, Glasgow RE, Lewis CL, Fairclough DL, Helmkamp LJ, Fitzgerald MD, Tzou WS, Kramer DB, Varosy PD, Gupta SK, Mandrola JM, Brancato SC, Peterson PN, Matlock DD. A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data. Am Heart J 2020;226:161-73. [PMID: 32599257 DOI: 10.1016/j.ahj.2020.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Auricchio A, Hudnall JH, Schloss EJ, Sterns LD, Kurita T, Meijer A, Fagan DH, Rogers T. Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis. Europace 2017;19:1973-80. [PMID: 28340005 DOI: 10.1093/europace/euw415] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
82 Looi KL, Lever N, Tang A, Agarwal S. Prophylactic implantable cardioverter defibrillator in heart failure: the growing evidence for all or Primum non nocere for some? Heart Fail Rev 2017;22:305-16. [PMID: 28229272 DOI: 10.1007/s10741-017-9602-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Kini V, Soufi MK, Deo R, Epstein AE, Bala R, Riley M, Groeneveld PW, Shalaby A, Dixit S. Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met? J Am Coll Cardiol 2014;63:2388-94. [PMID: 24727249 DOI: 10.1016/j.jacc.2014.03.025] [Cited by in Crossref: 99] [Cited by in F6Publishing: 65] [Article Influence: 14.1] [Reference Citation Analysis]
84 Tsukahara K, Oginosawa Y, Fujino Y, Honda T, Kikuchi K, Nozoe M, Uchida T, Minamiguchi H, Sonoda K, Ogawa M, Ideguchi T, Kizaki Y, Nakamura T, Oba K, Higa S, Yoshida K, Yagyu K, Miyamoto T, Yamagishi Y, Ohe H, Kohno R, Kataoka M, Otsuji Y, Abe H. RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy. J Arrhythm 2021;37:1052-60. [PMID: 34386132 DOI: 10.1002/joa3.12551] [Reference Citation Analysis]
85 Daubert JC, Donal E, Linde C. A plea for the wider use of CRT-P in candidates for cardiac resynchronisation therapy. Heart Fail Rev 2012;17:767-75. [PMID: 21786181 DOI: 10.1007/s10741-011-9277-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
86 Hadwiger M, Frielitz FS, Eisemann N, Elsner C, Dagres N, Hindricks G, Katalinic A. Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator. Appl Health Econ Health Policy 2021;19:57-68. [PMID: 32215877 DOI: 10.1007/s40258-020-00571-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
87 Deng D, Arevalo HJ, Prakosa A, Callans DJ, Trayanova NA. A feasibility study of arrhythmia risk prediction in patients with myocardial infarction and preserved ejection fraction. Europace 2016;18:iv60-6. [PMID: 28011832 DOI: 10.1093/europace/euw351] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
88 Fleeman BE, Aleong RG. Optimal Strategies to Reduce Inappropriate Implantable Cardioverter-defibrillator Shocks. J Innov Card Rhythm Manag 2019;10:3623-32. [PMID: 32477727 DOI: 10.19102/icrm.2019.100403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Stewart GC, Weintraub JR, Pratibhu PP, Semigran MJ, Camuso JM, Brooks K, Tsang SW, Anello MS, Nguyen VT, Lewis EF, Nohria A, Desai AS, Givertz MM, Stevenson LW. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail 2010;16:106-13. [PMID: 20142021 DOI: 10.1016/j.cardfail.2009.09.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 66] [Article Influence: 7.6] [Reference Citation Analysis]
90 Chatterjee NA, Rea TD. Secondary prevention of sudden cardiac death. Heart Rhythm O2 2020;1:297-310. [PMID: 34113884 DOI: 10.1016/j.hroo.2020.08.002] [Reference Citation Analysis]
91 Scheurlen C, van den Bruck J, Wörmann J, Plenge T, Sultan A, Steven D, Lüker J. ICD therapy in the elderly: a retrospective single-center analysis of mortality. Herzschrittmacherther Elektrophysiol 2021;32:250-6. [PMID: 33512593 DOI: 10.1007/s00399-021-00742-x] [Reference Citation Analysis]
92 Calo' L, Martino A, Tota C, Fagagnini A, Iulianella R, Rebecchi M, Sciarra L, Giunta G, Romano MG, Colaceci R, Ciccaglioni A, Ammirati F, de Ruvo E. Comparison of partners-heart failure algorithm vs care alert in remote heart failure management. World J Cardiol 2015;7:922-30. [PMID: 26730298 DOI: 10.4330/wjc.v7.i12.922] [Reference Citation Analysis]
93 Horlbeck FW, Schwab JO. Programming implantable cardioverter/defibrillators and outcomes. F1000Prime Rep 2015;7:10. [PMID: 25705393 DOI: 10.12703/P7-10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Tao S, Ashikaga H, Ciuffo LA, Yoneyama K, Lima JAC, Frank TF, Weiss RG, Tomaselli GF, Wu KC. Impaired left atrial function predicts inappropriate shocks in primary prevention implantable cardioverter-defibrillator candidates. J Cardiovasc Electrophysiol 2017;28:796-805. [PMID: 28429529 DOI: 10.1111/jce.13234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
95 Arenal A, Proclemer A, Kloppe A, Lunati M, Martìnez Ferrer JB, Hersi A, Gulaj M, Wijffels MC, Santi E, Manotta L, Mangoni L, Gasparini M. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Europace 2016;18:1719-25. [PMID: 27485577 DOI: 10.1093/europace/euw032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
96 Mahapatra S, LaPar DJ, Bhamidipati CM, McDaniel G, Kamath S, Bunch TJ, Ailawadi G. Incidence, risk factors, and consequences of new-onset atrial fibrillation following epicardial ablation for ventricular tachycardia. Europace 2011;13:548-54. [PMID: 21296778 DOI: 10.1093/europace/eur017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
97 Schupp T, Akin I, Reiser L, Bollow A, Taton G, Reichelt T, Ellguth D, Engelke N, Ansari U, Mashayekhi K, Weiß C, Nienaber C, Akin M, Borggrefe M, Behnes M. Prognostic impact of recurrences of ventricular tachyarrhythmias and appropriate ICD therapies in a high-risk ICD population. Clin Res Cardiol 2019;108:878-91. [PMID: 30756152 DOI: 10.1007/s00392-019-01416-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
98 Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death. Circ Arrhythm Electrophysiol 2016;9:e003283. [PMID: 26921377 DOI: 10.1161/CIRCEP.115.003283] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 6.8] [Reference Citation Analysis]
99 Higuchi T, Tsutsumi Y, Monta O, Asada S, Matsumoto R, Yamada S, Ohashi H. Surgical treatment for endocardial radiofrequency ablation-resistant sustained monomorphic ventricular tachycardia with mural thrombus including dense calcification in the left ventricle. Gen Thorac Cardiovasc Surg. 2017; Epub ahead of print. [PMID: 29188428 DOI: 10.1007/s11748-017-0853-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Brewster J, Sexton T, Dhaliwal G, Charnigo R, Morales G, Parrott K, Darrat Y, Gurley J, Smyth S, Elayi CS. Acute Effects of Implantable Cardioverter-Defibrillator Shocks on Biomarkers of Myocardial Injury, Apoptosis, Heart Failure, and Systemic Inflammation. Pacing Clin Electrophysiol 2017;40:344-52. [PMID: 28156007 DOI: 10.1111/pace.13037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
101 Romero J, Chaudhary R, Garg J, Lupercio F, Shah N, Gupta R, Nazir T, Bozorgnia B, Natale A, Di Biase L. Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials. J Interv Card Electrophysiol 2017;49:263-70. [PMID: 28674918 DOI: 10.1007/s10840-017-0260-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
102 Bloom HL. Treatment of ventricular tachycardia: consider ablation sooner. F1000 Med Rep 2009;1:71. [PMID: 20948708 DOI: 10.3410/M1-71] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
103 Muser D, Santangeli P, Liang JJ. Management of ventricular tachycardia storm in patients with structural heart disease. World J Cardiol 2017;9:521-30. [PMID: 28706587 DOI: 10.4330/wjc.v9.i6.521] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
104 Alvi RM, Neilan AM, Tariq N, Awadalla M, Rokicki A, Hassan M, Afshar M, Mulligan CP, Triant VA, Zanni MV, Neilan TG. Incidence, Predictors, and Outcomes of Implantable Cardioverter-Defibrillator Discharge Among People Living With HIV. J Am Heart Assoc 2018;7:e009857. [PMID: 30371221 DOI: 10.1161/JAHA.118.009857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
105 Sood N, Al Badarin F, Parker M, Pullatt R, Jacobson AF, Bateman TM, Heller GV. Resting perfusion MPI-SPECT combined with cardiac 123I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial. J Nucl Cardiol. 2013;20:813-820. [PMID: 23864400 DOI: 10.1007/s12350-013-9750-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
106 Hajduk AM, Gurwitz JH, Tabada G, Masoudi FA, Magid DJ, Greenlee RT, Sung SH, Cassidy-Bushrow AE, Liu TI, Reynolds K, Smith DH, Fiocchi F, Goldberg R, Gill TM, Gupta N, Peterson PN, Schuger C, Vidaillet H, Hammill SC, Allore H, Go AS; Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter Defibrillators. Influence of Multimorbidity on Burden and Appropriateness of Implantable Cardioverter-Defibrillator Therapies. J Am Geriatr Soc 2019;67:1370-8. [PMID: 30892695 DOI: 10.1111/jgs.15839] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
107 Schwab JO, Bonnemeier H, Kleemann T, Brachmann J, Fischer S, Birkenhauer F, Eberhardt F. Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study. Clin Res Cardiol 2015;104:1021-32. [PMID: 26002818 DOI: 10.1007/s00392-015-0870-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
108 Arai S, Kawamura M, Gokan T, Yoshikawa K, Ogawa K, Ochi A, Munetsugu Y, Ito H, Shinke T. Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator. Clin Cardiol 2020;43:1517-23. [PMID: 32989791 DOI: 10.1002/clc.23471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Dusi V, Gornbein J, Do DH, Sorg JM, Khakpour H, Krokhaleva Y, Ajijola OA, Macias C, Bradfield JS, Buch E, Fujimura OA, Boyle NG, Yanagawa J, Lee JM, Shivkumar K, Vaseghi M. Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation. J Am Heart Assoc 2021;10:e018371. [PMID: 33441022 DOI: 10.1161/JAHA.120.018371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
110 Radinovic A, Baratto F, Della Bella P. Optimal Timing of VT Ablation for Patients with ICD Therapies. Curr Cardiol Rep 2020;22:91. [PMID: 32648057 DOI: 10.1007/s11886-020-01345-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
111 Narayanan K, Reinier K, Teodorescu C, Uy-Evanado A, Aleong R, Chugh H, Nichols GA, Gunson K, London B, Jui J, Chugh SS. Left ventricular diameter and risk stratification for sudden cardiac death. J Am Heart Assoc 2014;3:e001193. [PMID: 25227407 DOI: 10.1161/JAHA.114.001193] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 5.1] [Reference Citation Analysis]
112 Ho LT, Chen JL, Chan HM, Huang YC, Su MY, Kuo SH, Chang YC, Lin JL, Chen WJ, Lee WJ, Lin LY. First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias. Sci Rep 2021;11:10360. [PMID: 33990651 DOI: 10.1038/s41598-021-89857-2] [Reference Citation Analysis]
113 Stempniewicz P, Cheng A, Connolly A, Wang XY, Calkins H, Tomaselli GF, Berger RD, Tereshchenko LG. Appropriate and inappropriate electrical therapies delivered by an implantable cardioverter-defibrillator: effect on intracardiac electrogram. J Cardiovasc Electrophysiol 2011;22:554-60. [PMID: 21087331 DOI: 10.1111/j.1540-8167.2010.01958.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
114 Mattsson G, Magnusson P. Long-term follow-up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality. Pacing Clin Electrophysiol 2020;43:245-53. [PMID: 31891421 DOI: 10.1111/pace.13869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
115 Tang PT, Do DH, Li A, Boyle NG. Team Management of the Ventricular Tachycardia Patient. Arrhythm Electrophysiol Rev 2018;7:238-46. [PMID: 30588311 DOI: 10.15420/aer.2018.37.2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
116 Callum K, Graune C, Bowman E, Molden E, Leslie SJ. Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area. World J Cardiol 2021;13:46-54. [PMID: 33791078 DOI: 10.4330/wjc.v13.i3.46] [Reference Citation Analysis]
117 Reinier K, Narayanan K, Uy-Evanado A, Teodorescu C, Chugh H, Mack WJ, Gunson K, Jui J, Chugh SS. Electrocardiographic Markers and the Left Ventricular Ejection Fraction have Cumulative Effects on Risk of Sudden Cardiac Death. JACC Clin Electrophysiol 2015;1:542-50. [PMID: 26949741 DOI: 10.1016/j.jacep.2015.07.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
118 Kawada S, Chakraborty P, Downar E, Sanchez AP, Sathananthan G, Bhaskaran A, Kugamoorthy P, Albertini L, Oechslin EN, Silversides C, Wald RM, Roche SL, Swan L, Alonso-Gonzalez R, Thorne S, Harris L, Hickey E, Nanthakumar K, Mondésert B, Khairy P, Nair K. The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator Shocks in Patients With Tetralogy of Fallot. CJC Open 2021;3:619-26. [PMID: 34027366 DOI: 10.1016/j.cjco.2021.01.005] [Reference Citation Analysis]
119 Theuns DA, Schaer BA, Soliman OI, Altmann D, Sticherling C, Geleijnse ML, Osswald S, Jordaens L. The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace 2011;13:62-9. [PMID: 20833692 DOI: 10.1093/europace/euq328] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
120 Maagh P, Christoph A, Dopp H, Mueller MS, Plehn G, Meissner A. High-Density Mapping in Ventricular Tachycardia Ablation: A PentaRay® Study. Cardiol Res 2017;8:293-303. [PMID: 29317972 DOI: 10.14740/cr636w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
121 Kutyifa V, Vermilye K, Daimee UA, McNitt S, Klein H, Moss AJ. Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death. Europace 2018;20:f225-32. [PMID: 29905788 DOI: 10.1093/europace/euy091] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
122 Kusumoto F, Goldschlager N. Remote monitoring of patients with implanted cardiac devices. Clin Cardiol 2010;33:10-7. [PMID: 20063296 DOI: 10.1002/clc.20688] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
123 Kaufman SR, Mueller PS, Ottenberg AL, Koenig BA. Ironic technology: Old age and the implantable cardioverter defibrillator in US health care. Soc Sci Med 2011;72:6-14. [PMID: 21126815 DOI: 10.1016/j.socscimed.2010.09.052] [Cited by in Crossref: 42] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
124 MacIntyre CJ, Sapp JL, Abdelwahab A, Al-Harbi M, Doucette S, Gray C, Gardner MJ, Parkash R. The Effect of Shock Burden on Heart Failure and Mortality. CJC Open 2019;1:161-7. [PMID: 32159102 DOI: 10.1016/j.cjco.2019.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
125 Bennett R, Turnbull S, Kotake Y, Campbell T, Kumar S. Ventricular Arrhythmia Burden as a Marker of Success Following Catheter Ablation of Ventricular Arrhythmias in Patients with Structural Heart Disease. Korean Circ J 2021;51:455-68. [PMID: 33764012 DOI: 10.4070/kcj.2020.0415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Silverstein JR, Katritsis DG, Josephson ME. Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention. Arrhythm Electrophysiol Rev 2012;1:46-50. [PMID: 26835029 DOI: 10.15420/aer.2012.1.46] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
127 Chery G, Kamp N, Kosinski AS, Schmidler GS, Lopes RD, Patel M, Al-Khatib SM. Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review. Am Heart J 2020;229:52-60. [PMID: 32916608 DOI: 10.1016/j.ahj.2020.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
128 Fong MW, Grazette L, Cesario D, Cao M, Saxon L. Treatment of ventricular tachycardia in patients with heart failure. Curr Cardiol Rep 2011;13:203-9. [PMID: 21445560 DOI: 10.1007/s11886-011-0182-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
129 Ganesh A, Qadri YJ, Boortz-Marx RL, Al-Khatib SM, Harpole DH Jr, Katz JN, Koontz JI, Mathew JP, Ray ND, Sun AY, Tong BC, Ulloa L, Piccini JP, Fudim M. Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias. Curr Hypertens Rep 2020;22:100. [PMID: 33097982 DOI: 10.1007/s11906-020-01111-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
130 Kampaktsis PN, Doulamis IP, Tzani A, Cheung JW. Preventive versus deferred catheter ablation of myocardial infarct-associated ventricular tachycardia: A meta-analysis. Heart Rhythm O2 2020;1:275-82. [PMID: 34113881 DOI: 10.1016/j.hroo.2020.08.001] [Reference Citation Analysis]
131 Kim EJ, Davogustto G, Stevenson WG, John RM. Non-invasive Cardiac Radiation for Ablation of Ventricular Tachycardia: a New Therapeutic Paradigm in Electrophysiology. Arrhythm Electrophysiol Rev 2018;7:8-10. [PMID: 29636967 DOI: 10.15420/aer.7.1.EO1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 4.7] [Reference Citation Analysis]
132 Fang Y, Gu K, Yang B, Ju W, Chen H, Li M, Liu H, Wang J, Yang G, Chen M. What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?-Results from over 1000 episodes. J Arrhythm 2018;34:36-45. [PMID: 29721112 DOI: 10.1002/joa3.12010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
133 Shahreyar M, Mupiddi V, Choudhuri I, Sra J, Tajik AJ, Jahangir A. Implantable cardioverter defibrillators in diabetics: efficacy and safety in patients at risk of sudden cardiac death. Expert Rev Cardiovasc Ther 2015;13:897-906. [PMID: 26098816 DOI: 10.1586/14779072.2015.1059276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
134 Reeder HT, Shen C, Buxton AE, Haneuse SJ, Kramer DB. Joint Shock/Death Risk Prediction Model for Patients Considering Implantable Cardioverter-Defibrillators. Circ Cardiovasc Qual Outcomes 2019;12:e005675. [PMID: 31412732 DOI: 10.1161/CIRCOUTCOMES.119.005675] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
135 Arısoy F, Ozcan Celebi O, Erbay İ, Tufekcioglu O, Aydoğdu S, Temizhan A. Selvester score predicts implantable cardioverter defibrillator shocks in patients with non-ischemic cardiomyopathy. J Arrhythm 2021;37:1046-51. [PMID: 34386131 DOI: 10.1002/joa3.12571] [Reference Citation Analysis]
136 Seegers J, Vos MA, Flevari P, Willems R, Sohns C, Vollmann D, Lüthje L, Kremastinos DT, Floré V, Meine M, Tuinenburg A, Myles RC, Simon D, Brockmöller J, Friede T, Hasenfuß G, Lehnart SE, Zabel M; EUTrigTreat Clinical Study Investigators. Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype. Europace 2012;14:416-22. [PMID: 22117037 DOI: 10.1093/europace/eur352] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
137 Friedman DJ, Altman RK, Orencole M, Picard MH, Ruskin JN, Singh JP, Heist EK. Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2012;5:762-72. [PMID: 22787010 DOI: 10.1161/CIRCEP.112.971101] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
138 Segreti L, Di Cori A, Zucchelli G, Soldati E, Coluccia G, Viani S, Paperini L, Bongiorni MG. A Questionable Indication For ICD Extraction After Successful VT Ablation. J Atr Fibrillation 2015;7:1172. [PMID: 27957158 DOI: 10.4022/jafib.1172] [Reference Citation Analysis]
139 Ishigaki D, Kutsuzawa D, Arimoto T, Iwayama T, Hashimoto N, Kumagai Y, Nishiyama S, Takahashi H, Shishido T, Miyamoto T, Nitobe J, Fukui A, Watanabe T, Kubota I. The association between defibrillation shock energy and acute cardiac damage in patients with implantable cardioverter defibrillators. J Arrhythm 2016;32:481-5. [PMID: 27920833 DOI: 10.1016/j.joa.2016.03.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
140 Bodin A, Labas V, Bisson A, Teixeira-Gomes AP, Blasco H, Tomas D, Combes-Soia L, Marcelo P, Miquelestorena-Standley E, Baron C, Angoulvant D, Babuty D, Clementy N. Acute pathophysiological myocardial changes following intra-cardiac electrical shocks using a proteomic approach in a sheep model. Sci Rep 2020;10:20252. [PMID: 33219330 DOI: 10.1038/s41598-020-77346-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Peterson PN, Greenlee RT, Go AS, Magid DJ, Cassidy-Bushrow A, Garcia-Montilla R, Glenn KA, Gurwitz JH, Hammill SC, Hayes J, Kadish A, Reynolds K, Sharma P, Smith DH, Varosy PD, Vidaillet H, Zeng CX, Normand ST, Masoudi FA. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J Am Heart Assoc 2017;6:e006937. [PMID: 29122811 DOI: 10.1161/JAHA.117.006937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
142 Maisch B, Pankuweit S. [Treatment of progressive heart failure: pharmacotherapy, resynchronization (CRT), surgery]. Herz 2010;35:94-101. [PMID: 20376643 DOI: 10.1007/s00059-010-3329-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
143 Lindvall C, Chatterjee NA, Chang Y, Chernack B, Jackson VA, Singh JP, Metlay JP. National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator. Circulation 2016;133:273-81. [PMID: 26635400 DOI: 10.1161/CIRCULATIONAHA.115.018830] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 5.8] [Reference Citation Analysis]
144 Lucignani G. Metaiodobenzylguanidine (mIBG) molecular imaging in implantable cardioverter defibrillator (ICD) therapy planning: a health technology assessment issue. Eur J Nucl Med Mol Imaging 2009;36:1346-50. [PMID: 19526230 DOI: 10.1007/s00259-009-1189-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
145 Graham AJ, Orini M, Lambiase PD. Limitations and Challenges in Mapping Ventricular Tachycardia: New Technologies and Future Directions. Arrhythm Electrophysiol Rev. 2017;6:118-124. [PMID: 29018519 DOI: 10.15420/aer.2017.20.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
146 Stoevelaar R, Brinkman-Stoppelenburg A, Bhagwandien RE, van Bruchem-Visser RL, Theuns DA, van der Heide A, Rietjens JA. The incidence and impact of implantable cardioverter defibrillator shocks in the last phase of life: An integrated review. Eur J Cardiovasc Nurs 2018;17:477-85. [PMID: 29772911 DOI: 10.1177/1474515118777421] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
147 Chatterjee NA, Roka A, Lubitz SA, Gold MR, Daubert C, Linde C, Steffel J, Singh JP, Mela T. Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review. Eur Heart J 2015;36:2780-9. [PMID: 26264552 DOI: 10.1093/eurheartj/ehv373] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 7.2] [Reference Citation Analysis]
148 El-Battrawy I, Roterberg G, Liebe V, Ansari U, Lang S, Zhou X, Borggrefe M, Akin I. Implantable cardioverter-defibrillator in Brugada syndrome: Long-term follow-up. Clin Cardiol 2019;42:958-65. [PMID: 31441080 DOI: 10.1002/clc.23247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
149 Pimentel M, Zimerman LI, Rohde LE. Stratification of the risk of sudden death in nonischemic heart failure. Arq Bras Cardiol 2014;103:348-57. [PMID: 25352509 DOI: 10.5935/abc.20140125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
150 Sun H, Mou Y, Li Y, Li X, Chen Z, Duval K, Huang Z, Dai R, Tang L, Tian F. Carbon nanotube-based substrates promote cardiogenesis in brown adipose-derived stem cells via β1-integrin-dependent TGF-β1 signaling pathway. Int J Nanomedicine 2016;11:4381-95. [PMID: 27660434 DOI: 10.2147/IJN.S114357] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
151 Borne RT, Randolph T, Wang Y, Curtis JP, Peterson PN, Masoudi FA, Sandhu A, Zipse MM, Thomas K, Kutyifa V, Desai NR, Cha YM, Hsu JC, Russo AM. Analysis of Temporal Trends and Variation in the Use of Defibrillation Testing in Contemporary Practice. JAMA Netw Open 2019;2:e1913553. [PMID: 31626314 DOI: 10.1001/jamanetworkopen.2019.13553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Pokorney SD, Friedman DJ, Calkins H, Callans DJ, Daoud EG, Della-Bella P, Jackson KP, Shivkumar K, Saba S, Sapp J, Stevenson WG, Al-Khatib SM. Catheter ablation of ventricular tachycardia: Lessons learned from past clinical trials and implications for future clinical trials. Heart Rhythm 2016;13:1748-54. [PMID: 27050910 DOI: 10.1016/j.hrthm.2016.04.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
153 Arevalo HJ, Vadakkumpadan F, Guallar E, Jebb A, Malamas P, Wu KC, Trayanova NA. Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models. Nat Commun 2016;7:11437. [PMID: 27164184 DOI: 10.1038/ncomms11437] [Cited by in Crossref: 171] [Cited by in F6Publishing: 108] [Article Influence: 34.2] [Reference Citation Analysis]
154 Kossaify A. Sensing and Detection Functions in Implantable Cardioverter Defibrillators: The Good, the Bad and the Ugly. Acta Cardiol Sin 2020;36:308-17. [PMID: 32675922 DOI: 10.6515/ACS.202007_36(4).20191201A] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
155 Bilchick KC, Stukenborg GJ, Kamath S, Cheng A. Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol 2012;60:1647-55. [PMID: 23021331 DOI: 10.1016/j.jacc.2012.07.028] [Cited by in Crossref: 128] [Cited by in F6Publishing: 95] [Article Influence: 14.2] [Reference Citation Analysis]
156 Saha P, Goldberger JJ. Risk stratification for prevention of sudden cardiac death. Curr Treat Options Cardiovasc Med 2012;14:81-90. [PMID: 22179949 DOI: 10.1007/s11936-011-0160-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
157 von Schacky C. Omega-3 Index and sudden cardiac death. Nutrients 2010;2:375-88. [PMID: 22254028 DOI: 10.3390/nu2030375] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
158 Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, Lombardo E, Regoli F, Biffi M, Burrone V, Denaro A, Boriani G. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J 2009;30:2758-67. [PMID: 19567380 DOI: 10.1093/eurheartj/ehp247] [Cited by in Crossref: 119] [Cited by in F6Publishing: 75] [Article Influence: 9.9] [Reference Citation Analysis]
159 Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm 2016;32:1-28. [PMID: 26949427 DOI: 10.1016/j.joa.2015.12.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
160 Voss F, Schueler M, Lauterbach M, Bauer A, Katus HA, Becker R. Safety of symptom-limited exercise testing in a big cohort of a modern ICD population. Clin Res Cardiol 2016;105:53-8. [PMID: 26123830 DOI: 10.1007/s00392-015-0885-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
161 Demarchi A, Cornara S, Sanzo A, Savastano S, Petracci B, Vicentini A, Pontillo L, Baldi E, Frigerio L, Astuti M, Leonardi S, Ghio S, Oltrona Visconti L, Rordorf R. Incidence of Ventricular Arrhythmias and 1-Year Predictors of Mortality in Patients Treated With Implantable Cardioverter-Defibrillator Undergoing Generator Replacement. J Am Heart Assoc 2021;10:e018090. [PMID: 33522246 DOI: 10.1161/JAHA.120.018090] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
162 Balci KG, Balci MM, Arslan U, Açar B, Maden O, Selcuk H, Selcuk T. Increased Platelet-to-Lymphocyte Ratios and Low Relative Lymphocyte Counts Predict Appropriate Shocks in Heart Failure Patients with ICDs. Acta Cardiol Sin 2016;32:542-9. [PMID: 27713602 DOI: 10.6515/acs20151012b] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
163 Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, Yu R, Vangala S, Tseng CH, Choi EK. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Heart Rhythm. 2015;12:1997-2007. [PMID: 26031376 DOI: 10.1016/j.hrthm.2015.05.036] [Cited by in Crossref: 258] [Cited by in F6Publishing: 152] [Article Influence: 43.0] [Reference Citation Analysis]
164 Gatterer E. [What must intensive care physicians know about implantable cardioverter defibrillator?]. Med Klin Intensivmed Notfmed 2013;108:569-77. [PMID: 24048444 DOI: 10.1007/s00063-013-0230-6] [Reference Citation Analysis]